Table 3.
Adjusted Odds Ratios and Their 95% CIs for the Presence of Each Category for Myopic Maculopathy in Choroidal Thickness Level, 2017
| No. of Events/Individuals |
Age-, Sex-, and Axial Length-Adjusted |
Multivariable-Adjusted∗ |
||||
|---|---|---|---|---|---|---|
| Q1 (CT < 138.5 μm) | Q2–Q4 (CT ≥ 138.5 μm) | Odds Ratio (95% CI) for Q1 (vs. Q2–Q4) | P | Odds Ratio (95% CI) for Q1 (vs. Q2–Q4) | P | |
| Myopic maculopathy | 62/710 | 19/2131 | 5.19 (2.89–9.32) | < 0.001 | 5.39 (2.96–9.81) | < 0.001 |
| Diffuse chorioretinal atrophy (category 2) | 35/693† | 10/2122† | 7.64 (3.57–16.35) | < 0.001 | 7.99 (3.69–17.26) | < 0.001 |
| Patchy chorioretinal atrophy (category 3) | 25/708‡ | 6/2128‡ | 5.50 (2.09–14.47) | < 0.001 | 6.12 (2.28–16.38) | < 0.001 |
| Macular atrophy (category 4) | 2/710 | 3/2131 | NA | NA | ||
CI = confidence interval; CT = choroidal thickness; NA = not assessed.
∗
Adjusted for age, sex, axial length, height, hypertension, diabetes mellitus, serum total cholesterol, smoking habits, and drinking habits.
†
Individuals with patchy chorioretinal atrophy (category 3) or macular atrophy (category 4) were excluded from the analysis.
‡
Individuals with macular atrophy (category 4) were excluded from the analysis.